- MYOK Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
MyoKardia (MYOK) Financial statements
Company Profile
Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | ||
---|---|---|---|---|---|---|
Total Revenue | ||||||
Cost of Revenue | ||||||
Gross Profit | ||||||
Gross Profit Margin (%) | ||||||
R&D Expense | ||||||
SG&A Expense | ||||||
Total Operating Expenses | ||||||
Operating Income or Loss | ||||||
Operating Margin (%) | ||||||
Interest Expense | ||||||
Total Other Income/Expenses | ||||||
Income Before Tax | ||||||
Income Tax Expense | ||||||
Income from Continuing Ops. | ||||||
Net Income | ||||||
Net Profit Margin (%) | ||||||
Net Income available to common shareholders | ||||||
Basic EPS | ||||||
Diluted EPS | ||||||
Basic Average Shares | ||||||
Diluted Average Shares |
Sep 2020 | Jun 2020 | Mar 2020 | Sep 2019 | Jun 2019 | Mar 2019 | Sep 2018 | Jun 2018 | Mar 2018 | Sep 2017 | Jun 2017 | Mar 2017 | Sep 2016 | Jun 2016 | Mar 2016 | Sep 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||||||||
Cost of Revenue | |||||||||||||||||
Gross Profit | |||||||||||||||||
Gross Profit Margin (%) | |||||||||||||||||
R&D Expense | |||||||||||||||||
SG&A Expense | |||||||||||||||||
Total Operating Expenses | |||||||||||||||||
Operating Income or Loss | |||||||||||||||||
Operating Margin (%) | |||||||||||||||||
Interest Expense | |||||||||||||||||
Total Other Income/Expenses | |||||||||||||||||
Income Before Tax | |||||||||||||||||
Income Tax Expense | |||||||||||||||||
Income from Continuing Ops. | |||||||||||||||||
Net Income | |||||||||||||||||
Net Profit Margin (%) | |||||||||||||||||
Net Income available to common shareholders | |||||||||||||||||
Basic EPS | |||||||||||||||||
Diluted EPS | |||||||||||||||||
Basic Average Shares | |||||||||||||||||
Diluted Average Shares |
Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | ||
---|---|---|---|---|---|---|
Current Assets | ||||||
Cash & Cash Equivalents | ||||||
Marketable Securities | ||||||
Receivables | ||||||
Inventories | ||||||
Other Current Assets | ||||||
Total Current Assets | ||||||
Non-Current Assets | ||||||
Marketable Securities | ||||||
PPE Net | ||||||
Intangibles inc. Goodwill | ||||||
Other Non-Current Assets | ||||||
Total Non-Current Assets | ||||||
Total Assets | ||||||
Current Liabilities | ||||||
Accounts Payable | ||||||
Deferred Revenues | ||||||
Debt, Current | ||||||
Accrued Liabilities | ||||||
Other Current Liabilities | ||||||
Total Current Liabilities | ||||||
Non-Current Liabilities | ||||||
Deferred Revenues | ||||||
Debt, Non-Current | ||||||
Other Non-Current Liabilities | ||||||
Total Non-Current Liabilities | ||||||
Total Liabilities | ||||||
Shareholders' Equity | ||||||
Common Stock | ||||||
Additional Paid-In Capital | ||||||
Retained Earnings | ||||||
Other Shareholders' Equity | ||||||
Total Shareholders' Equity | ||||||
Total Liabilities & Shareholders' Equity |
Sep 2020 | Jun 2020 | Mar 2020 | Sep 2019 | Jun 2019 | Mar 2019 | Sep 2018 | Jun 2018 | Mar 2018 | Sep 2017 | Jun 2017 | Mar 2017 | Sep 2016 | Jun 2016 | Mar 2016 | Sep 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||||||||
Cash & Cash Equivalents | |||||||||||||||||
Marketable Securities | |||||||||||||||||
Receivables | |||||||||||||||||
Inventories | |||||||||||||||||
Other Current Assets | |||||||||||||||||
Total Current Assets | |||||||||||||||||
Non-Current Assets | |||||||||||||||||
Marketable Securities | |||||||||||||||||
PPE Net | |||||||||||||||||
Intangibles inc. Goodwill | |||||||||||||||||
Other Non-Current Assets | |||||||||||||||||
Total Non-Current Assets | |||||||||||||||||
Total Assets | |||||||||||||||||
Current Liabilities | |||||||||||||||||
Accounts Payable | |||||||||||||||||
Deferred Revenues | |||||||||||||||||
Debt, Current | |||||||||||||||||
Accrued Liabilities | |||||||||||||||||
Other Current Liabilities | |||||||||||||||||
Total Current Liabilities | |||||||||||||||||
Non-Current Liabilities | |||||||||||||||||
Deferred Revenues | |||||||||||||||||
Debt, Non-Current | |||||||||||||||||
Other Non-Current Liabilities | |||||||||||||||||
Total Non-Current Liabilities | |||||||||||||||||
Total Liabilities | |||||||||||||||||
Shareholders' Equity | |||||||||||||||||
Common Stock | |||||||||||||||||
Additional Paid-In Capital | |||||||||||||||||
Retained Earnings | |||||||||||||||||
Other Shareholders' Equity | |||||||||||||||||
Total Shareholders' Equity | |||||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | ||
---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||
Net Income | ||||||
Depreciation & Amortization | ||||||
Deferred Income Taxes | ||||||
Stock Based Compensation | ||||||
Accounts Receivable | ||||||
Inventory | ||||||
Accounts Payable | ||||||
Deferred Revenue | ||||||
Other Non-Cash | ||||||
Operating Cash Flow | ||||||
Cash Flows from Investing Activities | ||||||
PPE Investments | ||||||
Net Acquisitions | ||||||
Purchase of Investments | ||||||
Sale of Investments | ||||||
Other Investing Activity | ||||||
Investing Cash Flow | ||||||
Cash Flows from Financing Activities | ||||||
Debt Issued | ||||||
Proceeds from Debt Repayment | ||||||
Debt Repayment | ||||||
Proceeds from Sale of Equity | ||||||
Equity Repurchased | ||||||
Dividend Paid | ||||||
Other Financing Activity | ||||||
Financing Cash Flow | ||||||
Cash Position | ||||||
Beginning Cash Position | ||||||
End Cash Position | ||||||
Change in Cash | ||||||
Free Cash Flow | ||||||
Operating Cash Flow | ||||||
Capital Expenditure | ||||||
Free Cash Flow |
Sep 2020 | Jun 2020 | Mar 2020 | Sep 2019 | Jun 2019 | Mar 2019 | Sep 2018 | Jun 2018 | Mar 2018 | Sep 2017 | Jun 2017 | Mar 2017 | Sep 2016 | Jun 2016 | Mar 2016 | Sep 2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||||||||
Net Income | |||||||||||||||||
Depreciation & Amortization | |||||||||||||||||
Deferred Income Taxes | |||||||||||||||||
Stock Based Compensation | |||||||||||||||||
Accounts Receivable | |||||||||||||||||
Inventory | |||||||||||||||||
Accounts Payable | |||||||||||||||||
Deferred Revenue | |||||||||||||||||
Other Non-Cash | |||||||||||||||||
Operating Cash Flow | |||||||||||||||||
Cash Flows from Investing Activities | |||||||||||||||||
PPE Investments | |||||||||||||||||
Net Acquisitions | |||||||||||||||||
Purchase of Investments | |||||||||||||||||
Sale of Investments | |||||||||||||||||
Other Investing Activity | |||||||||||||||||
Investing Cash Flow | |||||||||||||||||
Cash Flows from Financing Activities | |||||||||||||||||
Debt Issued | |||||||||||||||||
Proceeds from Debt Repayment | |||||||||||||||||
Debt Repayment | |||||||||||||||||
Proceeds from Sale of Equity | |||||||||||||||||
Equity Repurchased | |||||||||||||||||
Dividend Paid | |||||||||||||||||
Other Financing Activity | |||||||||||||||||
Financing Cash Flow | |||||||||||||||||
Cash Position | |||||||||||||||||
Beginning Cash Position | |||||||||||||||||
End Cash Position | |||||||||||||||||
Change in Cash | |||||||||||||||||
Free Cash Flow | |||||||||||||||||
Operating Cash Flow | |||||||||||||||||
Capital Expenditure | |||||||||||||||||
Free Cash Flow |